Steven J. Stanway

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2

Josie A. Blackie, Jackie C. Bloomer, Murray J. B. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 129 citations · Full text

Lipoprotein-associated Phospholipase A2, Biochemistry, Potent Inhibitor +8

Diels−Alder Exo Selectivity in Terminal-Substituted Dienes and Dienophiles: Experimental Discoveries and Computational Explanations

Yu‐hong Lam, Paul Ha‐Yeon Cheong, J. Miguel Mata et al. · Journal of the American Chemical Society · 2009 · 111 citations · Full text

Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206

Pamela Brown, Elizabeth Abbott, Omar Abdulle et al. · ACS Infectious Diseases · 2019 · 86 citations · Full text

BACE-1 inhibitors part 3: Identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells

Paul Beswick, Nicolas Charrier, Brian Clarke et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 57 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +10

Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A

Victoria A. Steadman, S. Pettit, Karine G. Poullennec et al. · Journal of Medicinal Chemistry · 2017 · 57 citations · Full text